EZZ Life Science Holdings Limited (ASX:EZZ)

Market Cap	95.76M
Revenue (ttm)	75.03M
Net Income (ttm)	9.02M
Shares Out	47.17M
EPS (ttm)	0.20
PE Ratio	9.99
Forward PE	11.47
Dividend	0.04 (1.97%)
Ex-Dividend Date	May 16, 2025

Volume	23,809
Average Volume	89,207
Open	2.100
Previous Close	2.030
Day's Range	2.030 - 2.100
52-Week Range	1.290 - 4.970
Beta	0.50
RSI	43.68
Earnings Date	Aug 28, 2025

About Accolade

EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally. The company operates through Brought in Lines and Company Owned Products segments. It is also involved in the wholesale distribution of the EAORON branded skin care products to retailers. In addition, the company engages in research, development, and sale of genomics. Further, it offers precision nutrition research products under the EZZ brand. EZZ Life Sci...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EZZ

Financial Performance

In 2024, EZZ Life Science Holdings's revenue was 66.44 million, an increase of 78.88% compared to the previous year's 37.14 million. Earnings were 6.96 million, an increase of 91.87%.